Advertisement
Research Article

A Potential Peptide Therapeutic Derived from the Juxtamembrane Domain of the Epidermal Growth Factor Receptor

  • Aislyn D. W. Boran,

    Affiliation: Department of Pharmacology and Systems Therapeutics, Mount Sinai School of Medicine, New York, New York, United States of America

    X
  • Joseph Seco,

    Affiliation: Department of Pharmacology and Systems Therapeutics, Mount Sinai School of Medicine, New York, New York, United States of America

    X
  • Vinodh Jayaraman,

    Affiliation: Department of Pharmacology and Systems Therapeutics, Mount Sinai School of Medicine, New York, New York, United States of America

    X
  • Gomathi Jayaraman,

    Affiliation: Department of Pharmacology and Systems Therapeutics, Mount Sinai School of Medicine, New York, New York, United States of America

    X
  • Shan Zhao,

    Affiliation: Department of Pharmacology and Systems Therapeutics, Mount Sinai School of Medicine, New York, New York, United States of America

    X
  • Sushmitha Reddy,

    Affiliation: Department of Pharmacology and Systems Therapeutics, Mount Sinai School of Medicine, New York, New York, United States of America

    X
  • Yibang Chen,

    Affiliation: Department of Pharmacology and Systems Therapeutics, Mount Sinai School of Medicine, New York, New York, United States of America

    X
  • Ravi Iyengar mail

    ravi.iyengar@mssm.edu

    Affiliation: Department of Pharmacology and Systems Therapeutics, Mount Sinai School of Medicine, New York, New York, United States of America

    X
  • Published: November 15, 2012
  • DOI: 10.1371/journal.pone.0049702

Media Coverage of this Article

Found additional news media or blog coverage for the article? Please let us know.